Umbilical cord blood transplantation: the first 20 years

Seminars in Hematology
John E Wagner, Eliane Gluckman

Abstract

In October 1988, the world's first umbilical cord blood transplant (UCBT) was performed. Despite considerable skepticism initially by both scientists and clinical specialists in the field, umbilical cord blood (UCB) has now become one of the most commonly used sources of hematopoietic stem cells (HSCs) for allogeneic transplantation. Today, an estimated 600,000 UCB units have been banked and 20,000 UCB units have been distributed worldwide for both adults and children with life-threatening malignant and nonmalignant diseases. During this first generation of UCBT, substantial advances have been made resulting in better outcomes for our patients. UCB serves as an extraordinary example of translational medicine at its best, where clinical problems compel scientists to move basic discoveries into novel therapeutic approaches. This chapter briefly summarizes the highpoints of the history of UCBT with speculations as to what the next generation of research promises to discover.

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H E BroxmeyerP Rubinstein
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H E BroxmeyerE A Boyse
Aug 31, 1989·Nature·D C Linch, L Brent
Oct 26, 1989·The New England Journal of Medicine·D G Nathan
Feb 9, 1995·The New England Journal of Medicine·S IssaragrisilA Piankijagum
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·R N PahwaR A Good
Jul 18, 1996·The New England Journal of Medicine·J P LaporteA Najman
Feb 15, 2001·Journal of Hematotherapy & Stem Cell Research·R A Good
Jul 21, 2004·The Journal of Experimental Medicine·Gesine KöglerPeter Wernet
Aug 20, 2008·Expert Opinion on Pharmacotherapy·Minghui LiWilliam J Murphy

❮ Previous
Next ❯

Citations

Aug 27, 2010·Current Opinion in Hematology·Sharon Avery, Juliet N Barker
Oct 26, 2012·Bone Marrow Research·Catherine Stavropoulos-GiokasAndreas Papassavas
Nov 23, 2012·Journal of Translational Medicine·J Christopher MizerAmit N Patel
Jan 1, 2011·Revista brasileira de hematologia e hemoterapia·Maria José Dantas CoêlhoFrancimary de Oliveira Cavalcante
Dec 1, 2012·Stem Cells Translational Medicine·Gary Van Zant, Ying Liang
Jul 3, 2013·Mayo Clinic Proceedings·Andre Terzic, Timothy J Nelson
Dec 5, 2012·Seminars in Oncology·Jean-Philippe BastienDenis Claude Roy
Jun 1, 2012·Pediatric Transplantation·Rupert Handgretinger
Jul 19, 2012·Transfusion·Sherri M BroderAaron J Goldenberg
Feb 26, 2013·Transfusion·J N Mehrishi, Tibor Bakács
Sep 16, 2010·Annals of the New York Academy of Sciences·Xiao Yan ZhongWolfgang Holzgreve
Aug 21, 2012·Annals of the New York Academy of Sciences·Lena OevermannRupert Handgretinger
Jan 25, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·H WikellM Uhlin
Jan 17, 2013·Cytotherapy·Jan J Melenhorst
Jan 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John BarrettAlejandro Madrigal
Apr 26, 2011·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Katja Rosenkranz, Carola Meier
Jul 19, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A-K KimD-I Kim
Oct 22, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yi-Bin ChenVincent T Ho
Aug 25, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nishitha ReddyBipin N Savani
Aug 21, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·L CobellisN Colacurci
May 13, 2014·Cell Transplantation·Wise Young
Oct 21, 2011·Pharmaceuticals·Anna ArnoMarc G Jeschke
May 6, 2019·HLA : Immune Response Genetics·Vani SeshasubramanianSrinivasan Periathiruvadi
Sep 8, 2012·Current Opinion in Obstetrics & Gynecology·Christina P Ho, Narender N Bhatia
Jun 19, 2015·Journal of Pediatric Hematology/oncology·Alexandra Schifferli, Thomas Kühne
May 19, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Eman F BoteinAli M Shaltot
Jul 5, 2017·Biomedicines·Haitham AbdelhakimAyman Saad
Feb 17, 2021·Archives of Gynecology and Obstetrics·Anna FunkGwendolin Manegold-Brauer
Apr 1, 2021·Transplantation and Cellular Therapy·Georgios E ChristakopoulosAngela R Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.